{{knowledge objective
|Item_parent=Malaria
|Rank=B
|Heading=Know the treatment and principles of monitoring a severe malaria attack.
|Description=Management of severe malaria attacks
|Rubric=
|College=Parasitology (ANOFEL), Infectious and Tropical Diseases (CMIT)
|Contributors=Marie Gladys Robert,Marie-Pierre Brenier-Pinchart,Adela Angoulvant,Françoise Botterel,Marie-Laure Dardé,Florence Robert-Gangneux
|Order=10
|Identifiant=OIC-170-10-B
|Item_parent_short=Paludism
}}
- '''Intensive care unit or intensive care unit'''

- '''Treatment with IV artesunate as first-line treatment'''

o ATU

o At least 24 hours

- Treatment with IV quinine if artesunate is contraindicated

- '''Relai ''per os'' as soon as possible, always, regardless of the duration of artesunate treatment'''

o ACT: artemether - lumefantrine OR dihydroartemisinin - piperaquine

o 3 days

- Symptomatic management (filling, correction of hypoglycaemia and fluid and electrolyte disorders, etc.)

- Surveillance

o Clinical improvement and search for signs of haemolytic anaemia (treatment with artesunate)

o ECG before treatment and daily thereafter

o Normalisation of haematological and biochemical tests, in particular

§ CBC, haptoglobin, LDH (delayed haemolytic anaemia 14 to 21 days after treatment with artesunate)

§ Blood glucose (quinine treatment)

§ Parasitaemia check at D3, D7, and D28